Description
This product is lyophilized and requires reconstitution. It comes with a home kit.
Retatrutide is a next-generation triple agonist peptide that activates the GLP-1, GIP, and glucagon receptors, making it one of the most advanced therapies for weight management and metabolic optimization. By targeting multiple pathways that regulate appetite, glucose control, and energy expenditure, Retatrutide supports greater fat reduction and improved metabolic health compared to single- or dual-agonist medications.
Benefits
-
Promotes significant and sustained weight loss
-
Improves insulin sensitivity and glucose regulation
-
Reduces appetite and cravings while supporting satiety
-
May increase energy expenditure and metabolic rate
-
Supports cardiometabolic and liver health
Estimated duration: 13 weeks following standard titration: 0.5mg weekly for weeks 1-4, 1mg weekly for weeks 5-8, 1.5mg weekly for weeks 9-12, 2mg weekly for weeks ongoing
Estimated duration is based on dosing protocol, please check patient portal and double check your protocol.
Reviews
There are no reviews yet.